SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $27,354 | -99.6% | 755 | -99.8% | 0.00% | -100.0% |
| Q1 2020 | $6,237,000 | +110.3% | 346,666 | +488.6% | 0.05% | +325.0% |
| Q3 2018 | $2,966,000 | -85.8% | 58,900 | -83.2% | 0.01% | -85.7% |
| Q2 2018 | $20,948,000 | +43541.7% | 350,000 | +18321.1% | 0.08% | – |
| Q4 2016 | $48,000 | -93.4% | 1,900 | -94.7% | 0.00% | -100.0% |
| Q2 2016 | $725,000 | -95.0% | 35,600 | -96.2% | 0.01% | -95.5% |
| Q1 2016 | $14,407,000 | – | 944,746 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |